Hyundai Mobis Co. has come up with an in-house brainwave-based driver monitoring system that can reduce the risk of drowsy driving by up to one-third.
The system, dubbed M.Brain, is a wearable earpiece that continuously detects and analyzes drivers' brain activity.
The company has examined the actual effect of the technology through a pilot study on public buses in Gyeonggi Province over the past year in partnership with the Gyeonggi Research Institute.
According to the findings, drivers who used M.Brain saw their risk of careless driving during after-meal hours, when drowsy driving is most common, drop by up to 30 percent.
M.Brain helped minimize the danger of careless driving by roughly 20% on highways where drowsy driving can lead to multi-car accidents.
When sloppy driving was detected in real-time, the device helped drivers recover attention within 2.3 seconds by blasting an alarm over the speakers and vibrating the seat.
This is nearly three times faster than the 6.7 seconds it took non-M.Brain drivers to regain attention.


Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
NASA and SpaceX Target Crew-11 Undocking From ISS Amid Medical Concern
Tabletop particle accelerator could transform medicine and materials science
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



